Healthcare -
Biotechnology - NASDAQ - US
$ 5.16
-2.27 %
$ 46 M
Market Cap
-19.85
P/E
ICCC - GROSS PROFIT
Gross Profit ICCC - ImmuCell Corporation
4.4 M
LAST VALUE
-28.73%
2 YEAR CAGR
-3.28%
5 YEAR CAGR
3.69%
10 YEAR CAGR